Gene · 7356
Papers3,443
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,443
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-throughput bioprinting of the nasal epithelium using patient-derived nasal epithelial cells. | Biofabrication | 2023 | 37536321 | PubTator, text mining | PubMed |
| Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma. | Cell Death Dis | 2023 | 37532692 | PubTator, text mining | PubMed |
| The deubiquitinase UCHL3 mediates p300-dependent chemokine signaling in alveolar type II cells to promote pulmonary fibrosis. | Exp Mol Med | 2023 | 37524875 | PubTator, text mining | PubMed |
| Circulating CC16 and Asthma: A Population-based, Multicohort Study from Early Childhood through Adult Life. | Am J Respir Crit Care Med | 2023 | 37523710 | PubTator, text mining | PubMed |
| Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia. | iScience | 2023 | 37520727 | PubTator, text mining | PubMed |
| Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD. | Front Immunol | 2023 | 37520564 | PubTator, text mining | PubMed |
| Back to the Basics: Usefulness of Naturally Aged Mouse Models and Immunohistochemical and Quantitative Morphologic Methods in Studying Mechanisms of Lung Aging and Associated Diseases. | Biomedicines | 2023 | 37509714 | PubTator, text mining | PubMed |
| Predicting Lung Function Using Biomarkers in Alpha-1 Antitrypsin Deficiency. | Biomedicines | 2023 | 37509640 | PubTator, text mining | PubMed |
| Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids. | Cells | 2023 | 37508518 | PubTator, text mining | PubMed |
| Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination. | EBioMedicine | 2023 | 37506557 | PubTator, text mining | PubMed |
| Retracted: Predictive Value of Serum Markers SFRP1 and CC16 in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. | Evid Based Complement Alternat Med | 2023 | 37501870 | PubTator, text mining | PubMed |
| Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma. | Cancer Res | 2023 | 37477508 | PubTator, text mining | PubMed |
| Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022). | J Transl Med | 2023 | 37475035 | PubTator, text mining | PubMed |
| Characterizing the urinary proteome of prematurity-associated lung disease in school-aged children. | Respir Res | 2023 | 37474963 | PubTator, text mining | PubMed |
| Identifying a Lung Stem Cell Subpopulation by Combining Single-Cell Morphometrics, Organoid Culture, and Transcriptomics. | Stem Cells | 2023 | 37468433 | PubTator, text mining | PubMed |
| The lung mesenchyme in development, regeneration, and fibrosis. | J Clin Invest | 2023 | 37463440 | PubTator, text mining | PubMed |
| Breathing on chip: Dynamic flow and stretch accelerate mucociliary maturation of airway epithelium in vitro. | Mater Today Bio | 2023 | 37455819 | PubTator, text mining | PubMed |
| Mesenchymal stem cells in lung diseases and their potential use in COVID-19 ARDS: A systematized review. | Clinics (Sao Paulo) | 2023 | 37454534 | PubTator, text mining | PubMed |
| Stem/Progenitor Cells and Related Therapy in Bronchopulmonary Dysplasia. | Int J Mol Sci | 2023 | 37446407 | PubTator, text mining | PubMed |
| Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE/EGFR signalling complex. | Eur Respir J | 2023 | 37442582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7356/papers?page=16